O. Rohr

发表

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line

R. König, J. Gatot, C. Van Lint, 2016, Scientific Reports.

Identification of Morphine-6-glucuronide in Chromaffin Cell Secretory Granules*

Arnaud H. Muller, D. Aunis, S. Chasserot-Golaz, 2006, Journal of Biological Chemistry.

Brain HIV-1 latently-infected reservoirs targeted by the suicide gene strategy

C. Schwartz, O. Rohr, M. Ravanshad, 2021, Virology journal.

HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters

C. Van Lint, Sebastian Eilebrecht, A. Benecke, 2014, Nucleic acids research.

CTIP2 is a negative regulator of P-TEFb

F. Dequiedt, C. Van Lint, X. Graña, 2013, Proceedings of the National Academy of Sciences.

Non-coding RNAs: novel players in chromatin-regulation during viral latency.

Sebastian Eilebrecht, Sebastian Eilebrecht, C. Schwartz, 2013, Current opinion in virology.

HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1

C. Van Lint, F. Forouzanfar, Sebastian Eilebrecht, 2016, Scientific Reports.

Chicken Ovalbumin Upstream Promoter Transcription Factor, a Transcriptional Activator of HIV-1 Gene Expression in Human Brain Cells*

D. Aunis, O. Rohr, B. Sawaya, 1996, The Journal of Biological Chemistry.

Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro

C. Schwartz, S. Pasquereau, O. Rohr, 2021, Viruses.

Brain HIV-1 latently-infected reservoirs targeted by the suicide gene strategy

C. Schwartz, O. Rohr, M. Ravanshad, 2020, Virology journal.

Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome

A. Burny, C. Van Lint, C. Vanhulle, 2016, Scientific Reports.

On the way to find a cure: Purging latent HIV‐1 reservoirs

C. Van Lint, C. Schwartz, S. Bouchat, 2017, Biochemical pharmacology.

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4 (cid:1) T lymphocytes

D. Aunis, C. Schwartz, O. Rohr, 2010 .

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1

B. Berkhout, C. Van Lint, C. Rouzioux, 2022, EBioMedicine.

In Trauma Patients, the Occurrence of Early-Onset Nosocomial Infections is Associated With Increased Plasma Concentrations of Chromogranin A

O. Rohr, M. Guillot, F. Schneider, 2017, Shock.

Toxoplasma gondii ROP16 kinase silences the cyclin B1 gene promoter by hijacking host cell UHRF1-dependent epigenetic pathways

S. Cianférani, S. Viville, O. Rohr, 2019, Cellular and Molecular Life Sciences.

The Many Lives of CTIP2: From AIDS to Cancer and Cardiac Hypertrophy

C. Schwartz, O. Rohr, T. Cherrier, 2014, Journal of cellular physiology.

[CTIP2, a multifunctional protein: cellular physiopathology and therapeutic implications].

C. Schwartz, O. Rohr, T. Cherrier, 2014, Medecine sciences : M/S.

DNA cytosine methylation in the Bovine Leukemia Virus promoter is associated with latency in a Lymphoma-derived B-cell line : potential involvement of direct inhibition of CREB/CREM/ATF binding

A. Burny, C. Van Lint, R. Kettmann, 2010, Journal of Biological Chemistry.

COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells

C. Van Lint, D. Aunis, S. Chasserot-Golaz, 2005, Nucleic acids research.

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs

C. Van Lint, A. Kula, A. Marcello, 2020, Frontiers in Microbiology.

Microglial Cells: The Main HIV-1 Reservoir in the Brain

C. Van Lint, A. Marcello, C. Schwartz, 2019, Front. Cell. Infect. Microbiol..

Regulation of HIV‐1 gene transcription: from lymphocytes to microglial cells

D. Aunis, O. Rohr, C. Marban, 2003, Journal of leukocyte biology.

p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1

D. Aunis, C. Schwartz, S. Zeichner, 2009, Oncogene.

Proceedings of the Frontiers of Retrovirology Conference 2016

R. König, D. Elleder, R. Sachidanandam, 2016, Retrovirology.

Targeting the Brain Reservoirs: Toward an HIV Cure

F. Forouzanfar, C. Schwartz, O. Rohr, 2016, Front. Immunol..

Suicide Gene Therapy in Cancer and HIV-1 infection: an alternative to conventional treatments.

C. Schwartz, O. Rohr, Sepideh Saeb, 2021, Biochemical pharmacology.

Targeting the DNA-PK complex: Its rationale use in cancer and HIV-1 infection.

C. Schwartz, O. Rohr, C. Wallet, 2019, Biochemical pharmacology.

Functional Interactions between C/EBP, Sp1, and COUP-TF Regulate Human Immunodeficiency Virus Type 1 Gene Transcription in Human Brain Cells

D. Aunis, C. Schwartz, O. Rohr, 2000, Journal of Virology.

Genome-Wide Binding Map of the HIV-1 Tat Protein to the Human Genome

M. Pellegrini, R. Ferrari, J. Zack, 2011, PloS one.

Achieving a cure for HIV infection: do we have reasons to be optimistic?

C. Schwartz, O. Rohr, Houda Hallay, 2012, The Journal of antimicrobial chemotherapy.

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Arsène Burny, Anna Kula, J. Gatot, 2015, PLoS pathogens.

Evolution of a concept: From accessory protein to key virulence factor, the case of HIV-1 Vpr.

C. Schwartz, O. Rohr, C. Wallet, 2020, Biochemical pharmacology.

LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing

C. Van Lint, D. Aunis, C. Schwartz, 2011, Nucleic acids research.

The Nuclear Receptor Chicken Ovalbumin Upstream Promoter Transcription Factor Interacts with HIV-1 Tat and Stimulates Viral Replication in Human Microglial Cells*

D. Aunis, C. Schwartz, M. Tardieu, 2000, The Journal of Biological Chemistry.

Reviewmechanisms of HIV-1 persistence in the monocyte-macrophage lineage

C. Schwartz, O. Rohr, G. Herbein, 2010 .

Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage

C. Schwartz, O. Rohr, G. Herbein, 2010, Retrovirology.

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients

J. Gatot, C. Van Lint, C. Rouzioux, 2012, AIDS.

Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage

C. Van Lint, B. Fahrenkrog, C. Schwartz, 2020, Scientific Reports.

HIV‐1 regulation of latency in the monocyte‐macrophage lineage and in CD4+ T lymphocytes

C. Van Lint, D. Aunis, C. Schwartz, 2010, Journal of leukocyte biology.

Novel Role of UHRF1 in DNA methylation-mediated repression of latent HIV-1

B. Berkhout, C. Rouzioux, F. Corazza, 2021, bioRxiv.

Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing

F. Dequiedt, C. Van Lint, D. Aunis, 2007, The EMBO journal.

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1

Anna Kula, J. Gatot, C. Van Lint, 2015, EMBO molecular medicine.

Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection

Arsène Burny, Dolores Vaira, J. Gatot, 2009, PloS one.

Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells

D. Aunis, S. Chasserot-Golaz, M. Leid, 2003, Journal of Virology.

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir

Anna Kula, C. Van Lint, C. Rouzioux, 2017, AIDS.

Improving combination antiretroviral therapy by targeting HIV-1 gene transcription

C. Schwartz, O. Rohr, C. Marban, 2016, Expert opinion on therapeutic targets.

COUP-TF and Sp1 Interact and Cooperate in the Transcriptional Activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Human Microglial Cells*

D. Aunis, O. Rohr, E. Schaeffer, 1997, The Journal of Biological Chemistry.

Analysis of RNA binding properties of human Ku protein reveals its interactions with 7SK snRNA and protein components of 7SK snRNP complex.

M. Gottikh, O. Rohr, T. Zatsepin, 2020, Biochimie.

gene promoter is epigenetically silenced by CTIP 2 and SUV 39 H 1

D. Aunis, C. Schwartz, O. Rohr, 2012 .

Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics

Guido Steiner, O. Rohr, T. Hickling, 2022, Pharmaceutics.

HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing

C. Van Lint, F. Forouzanfar, C. Schwartz, 2019, Scientific Reports.

Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation

D. Leprince, O. Rohr, H. Vorng, 2016, Molecular and Cellular Biology.

Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4 (cid:2) T-Cell Activation

D. Leprince, O. Rohr, H. Vorng, 2016 .

Mass spectrometry and CLIP-seq analysis reveal BCL11b interactions with RNA processing pathways

C. Van Lint, C. Schwartz, O. Rohr, 2020, bioRxiv.

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites

A. Burny, C. Van Lint, A. Kula, 2017, Scientific Reports.

CREB and COUP‐tF mediate transcriptional activation of the human immunodeficiency virus type 1 genome in jurkat t cells in response to cyclic AMP and dopamine

D. Aunis, C. Schwartz, O. Rohr, 1999, Journal of cellular biochemistry.

Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system.

D. Aunis, O. Rohr, B. Sawaya, 1999, Nucleic acids research.

Chromatin disruption in the promoter of Bovine Leukemia Virus during transcriptional activation

A. Burny, C. Van Lint, Laurence Colin, 2011, Nucleic acids research.

Pseudomonas DING proteins as human transcriptional regulators and HIV-1 antagonists

C. Schwartz, O. Rohr, Valentin Le Douce, 2013, Virology Journal.

The Level of DING Proteins Is Increased in HIV-Infected Patients: In Vitro and In Vivo Studies

M. Elias, E. Chabrière, J. Joven, 2012, PloS one.

Human-Phosphate-Binding-Protein inhibits HIV-1 gene transcription and replication

P. Masson, M. Elias, E. Chabrière, 2011, Virology Journal.

Targeting and eradicating latent CNS reservoirs of HIV-1: original strategies and new models.

C. Schwartz, O. Rohr, Sepideh Saeb, 2023, Biochemical pharmacology.

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency

C. Van Lint, O. Rohr, Anna Kula-Pacurar, 2023, Frontiers in Cellular and Infection Microbiology.

Proceedings of the Frontiers of Retrovirology Conference 2016

Sebastian A. Wagner, R. König, D. Elleder, 2016, Retrovirology.

Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage

C. Schwartz, O. Rohr, G. Herbein, 2015 .

Molecular Mechanisms of Hiv-1 Persistence in the Monocyte-macrophage Lineage. Open Access Review Molecular Mechanisms of Hiv-1 Persistence in the Monocyte-macrophage Lineage

C. Schwartz, O. Rohr, G. Herbein, 2022 .

Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

C. Schwartz, O. Rohr, G. Herbein, 2010, Retrovirology.

The AP-1 Binding Sites Located in the pol Gene Intragenic Regulatory Region of HIV-1 Are Important for Viral Replication

A. Bergamaschi, A. Burny, C. Van Lint, 2009, PLoS ONE.

Regulation of Human Immunodeficiency Virus Type 1 Gene Transcription by Nuclear Receptors in Human Brain Cells*

D. Aunis, O. Rohr, B. Sawaya, 1996, The Journal of Biological Chemistry.

HIV‐1 regulation of latency in the monocyte‐macrophage lineage and in CD4+ T lymphocytes

C. Van Lint, D. Aunis, C. Schwartz, 2010, Journal of leukocyte biology.

DNA Cytosine Methylation in the Bovine Leukemia Virus Promoter Is Associated with Latency in a Lymphoma-derived B-cell Line

A. Burny, C. Van Lint, R. Kettmann, 2010, The Journal of Biological Chemistry.

[Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].

D. Aunis, C. Schwartz, O. Rohr, 2010, Medecine sciences : M/S.